Clinical Trial

Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)

Study acronym: LUSIP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, longitudinal, single-arm interventional study of lung cancer screening.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-01; most recent amendment 2026-06-22.
Trial Details
NCT Number NCT07279948
Lead Sponsor AstraZeneca
Conditions Lung Cancer
Enrollment 477 participants
Start Date 2026-08-31
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03